1
|
Choi S, Yoo S, Jeon M, Park S, Choi Y, An J, Jeon S, Lee M, Yun JH, Park JW, Kim I. SPATA20 deficiency enhances the metastatic and angiogenic potential of cancer cells by promoting HIF-1α synthesis. Am J Cancer Res 2024; 14:727-743. [PMID: 38455399 PMCID: PMC10915324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Accepted: 02/05/2024] [Indexed: 03/09/2024] Open
Abstract
Hypoxia-inducible factors (HIFs) regulate cellular oxygen balance and play a central role in cancer metastasis and angiogenesis. Despite extensive research on HIFs, successful therapeutic strategies remain limited due to the intricate nature of their regulation. In this study, we identified SPATA20, a relatively understudied protein with a thioredoxin-like domain, as an upstream regulator of HIF-1α. Depleting SPATA20 induced HIF-1α expression, suggesting a tumor-suppressive role for SPATA20 in cancer cells. SPATA20 depletion increased HIF-1α protein levels and transcriptional activity without affecting its degradation. It appears that SPATA20 inhibits the de novo synthesis of HIF-1α, possibly by repressing the cap-dependent translation process involving AKT phosphorylation. Additionally, depletion of SPATA20 promoted cancer cell migration and invasion, which can be reversed by pharmacological inhibition of HIF-1α. Clinical data analysis revealed an inverse correlation between SPATA20 expression and colorectal cancer progression, providing evidence of its role as a potential biomarker. Utilizing SPATA20 as an indicator for HIF-1α-targeting therapy may be an attractive strategy for treating patients with hypoxia-driven cancers. In conclusion, this study demonstrates that SPATA20 deficiency promotes cancer progression by activating the HIF-1α signaling pathway.
Collapse
Affiliation(s)
- Sanga Choi
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Seongkyeong Yoo
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Miyeon Jeon
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Soohyun Park
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Yunsup Choi
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Jiyeon An
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Sungmi Jeon
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of MedicineSeoul 03080, South Korea
| | - Mingyu Lee
- Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital and Department of Medicine, Harvard Medical SchoolBoston, MA 02115, USA
| | - Jang-Hyuk Yun
- College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National UniversityChuncheon 24341, South Korea
| | - Jong-Wan Park
- Department of Pharmacology, Seoul National University College of MedicineSeoul 03080, South Korea
| | - Iljin Kim
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| |
Collapse
|
2
|
Jeon S, Kim I, Jeong YJ, Kim Y, Chung JJ, Kim SW. Comparative Analysis of Antibacterial and Wound Healing Activities of Chitosan and Povidone-Iodine-Based Hydrogels. Ann Plast Surg 2024; 92:240-244. [PMID: 38198629 DOI: 10.1097/sap.0000000000003755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2024]
Abstract
PURPOSE This study aimed to compare the antibacterial and wound healing efficacies of chitosan hydrogel with povidone-iodine (PI) hydrogel. METHODS The in vitro antibacterial activities of chitosan and PI hydrogels against Staphylococcus aureus and Escherichia coli were evaluated. Nine 6- to 8-week-old male Sprague-Dawley rats were divided into plain, PI, and chitosan hydrogel groups. Each rat received two 10-mm full-thickness dorsal wounds using an excisional splinting model. Each wound was treated with 0.2 mL of gel thrice over the course of 3 postoperative weeks. Weekly observations were conducted, and at the end of the third postoperative week, the rats were killed for histopathological and quantitative polymerase chain reaction evaluations. Data analysis included both 2- and 1-way analyses of variance. RESULTS Chitosan hydrogel exhibited comparable in vitro antibacterial activity and a significantly enhanced in vivo wound closure rate compared with PI hydrogel. Three weeks after the surgery, the chitosan hydrogel group demonstrated marked differences in wound repair (P < 0.01). Histologically, increased collagen deposition was observed with chitosan hydrogel treatment. Immunohistochemistry for CD68 revealed a lower number of macrophages in the wounds treated with chitosan hydrogel. Quantitative polymerase chain reaction analysis indicated a superior collagen 1 to 3 ratio and reduced expression of proinflammatory cytokine mRNAs (interleukin 1b, interleukin 6, tumor necrosis factor α, and interferon γ) in the chitosan hydrogel group. CONCLUSION Chitosan hydrogel demonstrates the potential to serve as an effective alternative to PI hydrogel, providing enhanced wound healing capabilities while maintaining comparable antimicrobial properties.
Collapse
Affiliation(s)
| | - Iljin Kim
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of Medicine, Incheon
| | - Yu Jin Jeong
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul
| | | | | | - Sang Wha Kim
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul
| |
Collapse
|
3
|
Arnquist IJ, Avignone FT, Barabash AS, Barton CJ, Bhimani KH, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Chan YD, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Efremenko Y, Ejiri H, Elliott SR, Giovanetti GK, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Henning R, Hervas Aguilar D, Hoppe EW, Hostiuc A, Kidd MF, Kim I, Kouzes RT, Lannen V TE, Li A, Lopez AM, López-Castaño JM, Martin EL, Martin RD, Massarczyk R, Meijer SJ, Mertens S, Oli TK, Othman G, Paudel LS, Pettus W, Poon AWP, Radford DC, Rager J, Reine AL, Rielage K, Ruof NW, Schaper DC, Tedeschi D, Varner RL, Vasilyev S, Wilkerson JF, Wiseman C, Xu W, Yu CH, Zhu BX. Exotic Dark Matter Search with the Majorana Demonstrator. Phys Rev Lett 2024; 132:041001. [PMID: 38335333 DOI: 10.1103/physrevlett.132.041001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 09/08/2023] [Accepted: 11/09/2023] [Indexed: 02/12/2024]
Abstract
With excellent energy resolution and ultralow-level radiogenic backgrounds, the high-purity germanium detectors in the Majorana Demonstrator enable searches for several classes of exotic dark matter (DM) models. In this work, we report new experimental limits on keV-scale sterile neutrino DM via the transition magnetic moment from conversion to active neutrinos ν_{s}→ν_{a}. We report new limits on fermionic dark matter absorption (χ+A→ν+A) and sub-GeV DM-nucleus 3→2 scattering (χ+χ+A→ϕ+A), and new exclusion limits for bosonic dark matter (axionlike particles and dark photons). These searches utilize the (1-100)-keV low-energy region of a 37.5-kg y exposure collected by the Demonstrator between May 2016 and November 2019 using a set of ^{76}Ge-enriched detectors whose surface exposure time was carefully controlled, resulting in extremely low levels of cosmogenic activation.
Collapse
Affiliation(s)
- I J Arnquist
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - A S Barabash
- National Research Center "Kurchatov Institute" Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - C J Barton
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - K H Bhimani
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - E Blalock
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - B Bos
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - M Busch
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - M Buuck
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - T S Caldwell
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
| | - Y-D Chan
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - P-H Chu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M L Clark
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Cuesta
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, CIEMAT 28040, Madrid, Spain
| | - J A Detwiler
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - Yu Efremenko
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37916, USA
| | - H Ejiri
- Research Center for Nuclear Physics, Osaka University, Ibaraki, Osaka 567-0047, Japan
| | - S R Elliott
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - G K Giovanetti
- Physics Department, Williams College, Williamstown, Massachusetts 01267, USA
| | - M P Green
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - J Gruszko
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - I S Guinn
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - V E Guiseppe
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - C R Haufe
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R Henning
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - D Hervas Aguilar
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - E W Hoppe
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - A Hostiuc
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - M F Kidd
- Tennessee Tech University, Cookeville, Tennessee 38505, USA
| | - I Kim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - R T Kouzes
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - T E Lannen V
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A Li
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - A M Lopez
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37916, USA
| | | | - E L Martin
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R D Martin
- Department of Physics, Engineering Physics and Astronomy, Queen's University, Kingston, Ontario K7L 3N6, Canada
| | - R Massarczyk
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S J Meijer
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S Mertens
- Max-Planck-Institut für Physik, München 80805, Germany
- Physik Department and Excellence Cluster Universe, Technische Universität, München 85748, Germany
| | - T K Oli
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - G Othman
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - L S Paudel
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - W Pettus
- IU Center for Exploration of Energy and Matter, and Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - A W P Poon
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - D C Radford
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - J Rager
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
| | - A L Reine
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - K Rielage
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - N W Ruof
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - D C Schaper
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D Tedeschi
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - R L Varner
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - S Vasilyev
- Joint Institute for Nuclear Research, Dubna 141980, Russia
| | - J F Wilkerson
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Wiseman
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - W Xu
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - C-H Yu
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - B X Zhu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| |
Collapse
|
4
|
Yoo S, Choi S, Kim I, Kim IS. Hypoxic regulation of extracellular vesicles: Implications for cancer therapy. J Control Release 2023; 363:201-220. [PMID: 37739015 DOI: 10.1016/j.jconrel.2023.09.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 08/18/2023] [Accepted: 09/18/2023] [Indexed: 09/24/2023]
Abstract
Extracellular vesicles (EVs) play a pivotal role in intercellular communication and have been implicated in cancer progression. Hypoxia, a pervasive hallmark of cancer, is known to regulate EV biogenesis and function. Hypoxic EVs contain a specific set of proteins, nucleic acids, lipids, and metabolites, capable of reprogramming the biology and fate of recipient cells. Enhancing the intrinsic therapeutic efficacy of EVs can be achieved by strategically modifying their structure and contents. Moreover, the use of EVs as drug delivery vehicles holds great promise for cancer treatment. However, various hurdles must be overcome to enable their clinical application as cancer therapeutics. In this review, we aim to discuss the current knowledge on the hypoxic regulation of EVs. Additionally, we will describe the underlying mechanisms by which EVs contribute to cancer progression in hypoxia and outline the progress and limitations of hypoxia-related EV therapeutics for cancer.
Collapse
Affiliation(s)
- Seongkyeong Yoo
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of Medicine, Incheon 22212, South Korea; Research Center for Controlling Intercellular Communication, Inha University College of Medicine, Incheon 22212, South Korea
| | - Sanga Choi
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of Medicine, Incheon 22212, South Korea; Research Center for Controlling Intercellular Communication, Inha University College of Medicine, Incheon 22212, South Korea
| | - Iljin Kim
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of Medicine, Incheon 22212, South Korea; Research Center for Controlling Intercellular Communication, Inha University College of Medicine, Incheon 22212, South Korea.
| | - In-San Kim
- KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, South Korea; Chemical and Biological Integrative Research Center, Biomedical Research Institute, Korea Institute Science and Technology, Seoul 02792, South Korea.
| |
Collapse
|
5
|
Arnquist IJ, Avignone FT, Barabash AS, Barton CJ, Bhimani KH, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Efremenko Y, Ejiri H, Elliott SR, Giovanetti GK, Goett J, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Henning R, Hervas Aguilar D, Hoppe EW, Hostiuc A, Kim I, Kouzes RT, Lannen V TE, Li A, López-Castaño JM, Massarczyk R, Meijer SJ, Meijer W, Oli TK, Paudel LS, Pettus W, Poon AWP, Radford DC, Reine AL, Rielage K, Rouyer A, Ruof NW, Schaper DC, Schleich SJ, Smith-Gandy TA, Tedeschi D, Thompson JD, Varner RL, Vasilyev S, Watkins SL, Wilkerson JF, Wiseman C, Xu W, Yu CH, Alves DSM, Hebenstiel L, Ramani H. Constraints on the Decay of ^{180m}Ta. Phys Rev Lett 2023; 131:152501. [PMID: 37897780 DOI: 10.1103/physrevlett.131.152501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/02/2023] [Revised: 08/15/2023] [Accepted: 09/12/2023] [Indexed: 10/30/2023]
Abstract
^{180m}Ta is a rare nuclear isomer whose decay has never been observed. Its remarkably long lifetime surpasses the half-lives of all other known β and electron capture decays due to the large K-spin differences and small energy differences between the isomeric and lower-energy states. Detecting its decay presents a significant experimental challenge but could shed light on neutrino-induced nucleosynthesis mechanisms, the nature of dark matter, and K-spin violation. For this study, we repurposed the Majorana Demonstrator, an experimental search for the neutrinoless double-beta decay of ^{76}Ge using an array of high-purity germanium detectors, to search for the decay of ^{180m}Ta. More than 17 kg, the largest amount of tantalum metal ever used for such a search, was installed within the ultralow-background detector array. In this Letter, we present results from the first year of Ta data taking and provide an updated limit for the ^{180m}Ta half-life on the different decay channels. With new limits up to 1.5×10^{19} yr, we improved existing limits by 1-2 orders of magnitude which are the most sensitive searches for a single β and electron capture decay ever achieved. Over all channels, the decay can be excluded for T_{1/2}<0.29×10^{18} yr.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - D S M Alves
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - L Hebenstiel
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
- IU Center for Exploration of Energy and Matter, and Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - H Ramani
- Stanford Institute for Theoretical Physics, Stanford University, Stanford, California 94305, USA
| |
Collapse
|
6
|
Jeon S, Kim I, Na YR, Yong Hong K, Chang H, Kim SH, Jeong YJ, Chung JH, Kim SW. Multiple Injections of Adipose-Derived Stem Cells Improve Graft Survival in Human-to-Rat Skin Xenotransplantation through Immune Modulation. Tissue Eng Regen Med 2023; 20:905-919. [PMID: 37531072 PMCID: PMC10519904 DOI: 10.1007/s13770-023-00552-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/02/2023] [Accepted: 05/09/2023] [Indexed: 08/03/2023] Open
Abstract
BACKGROUND Adipose-derived stem cells (ADSCs) exert immunomodulatory effects in the treatment of transplant rejection. This study aimed to evaluate the effects of ADSCs on the skin graft survival in a human-to-rat xenograft transplantation model and to compare single and multiple injections of ADSCs. METHODS Full-thickness human skin xenografts were transplanted into the backs of Sprague-Dawley rats. The rats were injected subcutaneously on postoperative days 0, 3, and 5. The injections were as follows: triple injections of phosphate-buffered saline (PBS group), a single injection of ADSCs and double injections of PBS (ADSC × 1 group), and triple injections of ADSCs (ADSC × 3 group). The immunomodulatory effects of ADSCs on human skin xenografts were assessed. RESULTS Triple injections of ADSCs considerably delayed cell-mediated xenograft rejection compared with the PBS and ADSC × 1 groups. The vascularization and collagen type 1-3 ratios in the ADSC × 3 group were significantly higher than those in the other groups. In addition, intragraft infiltration of CD3-, CD4-, CD8-, and CD68-positive cells was reduced in the ADSC × 3 group. Furthermore, in the ADSC × 3 group, the expression levels of proinflammatory cytokine interferon-gamma (IFN-γ) were decreased and immunosuppressive prostaglandin E synthase (PGES) was increased in the xenograft and lymph node samples. CONCLUSION This study presented that triple injections of ADSCs appeared to be superior to a single injection in suppressing cell-mediated xenograft rejection. The immunomodulatory effects of ADSCs are associated with the downregulation of IFN-γ and upregulation of PGES in skin xenografts and lymph nodes.
Collapse
Affiliation(s)
- Sungmi Jeon
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
- Department of Plastic and Reconstructive Surgery, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea
| | - Iljin Kim
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University, Incheon, 22212, Republic of Korea
| | - Yi Rang Na
- Department of Microbiology and Immunology, and Institute of Endemic Disease, Seoul National University Medical College, Seoul, Republic of Korea
- Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea
| | - Ki Yong Hong
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Hak Chang
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Seung Hwan Kim
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Yu Jin Jeong
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Jee Hyeok Chung
- Division of Pediatric Plastic Surgery, Seoul National University Children's Hospital, Seoul, Republic of Korea.
| | - Sang Wha Kim
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
| |
Collapse
|
7
|
Arnquist IJ, Avignone FT, Barabash AS, Barton CJ, Bhimani KH, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Chan YD, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Efremenko Y, Ejiri H, Elliott SR, Giovanetti GK, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Henning R, Hervas Aguilar D, Hoppe EW, Hostiuc A, Kim I, Kouzes RT, Lannen V TE, Li A, Lopez AM, López-Castaño JM, Martin EL, Martin RD, Massarczyk R, Meijer SJ, Oli TK, Othman G, Paudel LS, Pettus W, Poon AWP, Radford DC, Reine AL, Rielage K, Ruof NW, Tedeschi D, Varner RL, Vasilyev S, Wilkerson JF, Wiseman C, Xu W, Yu CH, Zhu BX. Erratum: Search for Spontaneous Radiation from Wave Function Collapse in the Majorana Demonstrator [Phys. Rev. Lett. 129, 080401 (2022)]. Phys Rev Lett 2023; 130:239902. [PMID: 37354428 DOI: 10.1103/physrevlett.130.239902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Indexed: 06/26/2023]
Abstract
This corrects the article DOI: 10.1103/PhysRevLett.129.080401.
Collapse
|
8
|
Kim I, Seo J, Lee DH, Kim YH, Kim JH, Wie MB, Byun JK, Yun JH. Ulmus davidiana 60% edible ethanolic extract for prevention of pericyte apoptosis in diabetic retinopathy. Front Endocrinol (Lausanne) 2023; 14:1138676. [PMID: 37234799 PMCID: PMC10206296 DOI: 10.3389/fendo.2023.1138676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/18/2023] [Accepted: 04/19/2023] [Indexed: 05/28/2023] Open
Abstract
Diabetic retinopathy (DR) is a disease that causes visual deficiency owing to vascular leakage or abnormal angiogenesis. Pericyte apoptosis is considered one of the main causes of vascular leakage in diabetic retina, but there are few known therapeutic agents that prevent it. Ulmus davidiana is a safe natural product that has been used in traditional medicine and is attracting attention as a potential treatment for various diseases, but its effect on pericyte loss or vascular leakage in DR is not known at all. In the present study, we investigated on the effects of 60% edible ethanolic extract of U. davidiana (U60E) and catechin 7-O-β-D-apiofuranoside (C7A), a compound of U. davidiana, on pericyte survival and endothelial permeability. U60E and C7A prevented pericyte apoptosis by inhibiting the activation of p38 and JNK induced by increased glucose and tumor necrosis factor alpha (TNF-α) levels in diabetic retina. Moreover, U60E and C7A reduced endothelial permeability by preventing pericyte apoptosis in co-cultures of pericytes and endothelial cells. These results suggest that U60E and C7A could be a potential therapeutic agent for reducing vascular leakage by preventing pericyte apoptosis in DR.
Collapse
Affiliation(s)
- Iljin Kim
- Department of Pharmacology, Inha University College of Medicine, Incheon, Republic of Korea
| | - Jieun Seo
- Faculty of Engineering, Yokohama National University, Yokohama, Japan
| | - Dong Hyun Lee
- Department of Ophthalmology, Inha University Hospital, Inha University College of Medicine, Incheon, Republic of Korea
| | - Yo-Han Kim
- College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon, Republic of Korea
| | - Jun-Hyung Kim
- College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon, Republic of Korea
| | - Myung-Bok Wie
- College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon, Republic of Korea
| | - Jun-Kyu Byun
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea
| | - Jang-Hyuk Yun
- College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon, Republic of Korea
| |
Collapse
|
9
|
Lee M, Kim YS, Lim S, Shin SH, Kim I, Kim J, Choi M, Kim JH, Koh SJ, Park JW, Shin HW. Protein stabilization of ITF2 by NF-κB prevents colitis-associated cancer development. Nat Commun 2023; 14:2363. [PMID: 37185280 PMCID: PMC10130090 DOI: 10.1038/s41467-023-38080-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Accepted: 04/14/2023] [Indexed: 05/17/2023] Open
Abstract
Chronic colonic inflammation is a feature of cancer and is strongly associated with tumorigenesis, but its underlying molecular mechanisms remain poorly understood. Inflammatory conditions increased ITF2 and p65 expression both ex vivo and in vivo, and ITF2 and p65 showed positive correlations. p65 overexpression stabilized ITF2 protein levels by interfering with the binding of Parkin to ITF2. More specifically, the C-terminus of p65 binds to the N-terminus of ITF2 and inhibits ubiquitination, thereby promoting ITF2 stabilization. Parkin acts as a E3 ubiquitin ligase for ITF2 ubiquitination. Intestinal epithelial-specific deletion of ITF2 facilitated nuclear translocation of p65 and thus increased colitis-associated cancer tumorigenesis, which was mediated by Azoxymethane/Dextran sulfate sodium or dextran sulfate sodium. Upregulated ITF2 expression was lost in carcinoma tissues of colitis-associated cancer patients, whereas p65 expression much more increased in both dysplastic and carcinoma regions. Therefore, these findings indicate a critical role for ITF2 in the repression of colitis-associated cancer progression and ITF2 would be an attractive target against inflammatory diseases including colitis-associated cancer.
Collapse
Affiliation(s)
- Mingyu Lee
- Division of Allergy and Clinical Immunology, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School, Boston, USA
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea
- Obstructive Upper airway Research (OUaR) Laboratory, Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Yi-Sook Kim
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea
- Obstructive Upper airway Research (OUaR) Laboratory, Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Suha Lim
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea
- Obstructive Upper airway Research (OUaR) Laboratory, Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Seung-Hyun Shin
- Hanmi Research Center, Hanmi Pharmaceutical Co. Ltd., 550 Dongtangiheung-ro, Hwaseong-si, 18469, Gyeonggi-do, South Korea
| | - Iljin Kim
- Department of Pharmacology, Inha University College of Medicine, Incheon, South Korea
| | - Jiyoung Kim
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
- Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Min Choi
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea
- Obstructive Upper airway Research (OUaR) Laboratory, Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Jung Ho Kim
- Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
| | - Seong-Joon Koh
- Liver Research Institute and Seoul National University College of Medicine, Seoul, South Korea
| | - Jong-Wan Park
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
- Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Hyun-Woo Shin
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea.
- Obstructive Upper airway Research (OUaR) Laboratory, Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
- Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, South Korea.
- Sensory Organ Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
| |
Collapse
|
10
|
Lee G, Park S, Lee S, Song K, Kim Y, Chang W, Kim J, Park N, Kim J, Park S, Hwang I, Kim H, Kim I. Bioimpedance Analysis as a Screening Tool in Heart-Transplanted Patients. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
11
|
Kim D, Youn J, Kim J, Kim I, Choi J, Kransdorf E, Chang D, Kittleson M, Patel J, Cole R, Moriguchi J, Esmailian F, Kobashigawa J. Clinical Outcomes of Heart Transplantation in Desensitized Durable Mechanical Circulatory Support Patients. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
12
|
Kim I, Youn J, Chang D, Nishihara K, Kransdorf E, Kittleson M, Patel J, Cole R, Nikolova A, Esmailian F, Czer L, Kobashigawa J. The Validation of Cardiac Rehabilitation after Heart Transplantation from Anonymized Patient-Reported Outcomes. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
13
|
Kim E, Lee S, Jang D, Kyoung Y, Kim J, Kim I, Kim J, Youn J. Proteomic Discovery of Molecular Pathways in Patients with Biopsy-Proven Myocarditis. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
14
|
Arnquist IJ, Avignone FT, Barabash AS, Barton CJ, Barton PJ, Bhimani KH, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Chan YD, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Efremenko Y, Ejiri H, Elliott SR, Giovanetti GK, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Henning R, Hervas Aguilar D, Hoppe EW, Hostiuc A, Kidd MF, Kim I, Kouzes RT, Lannen V TE, Li A, Lopez AM, López-Castaño JM, Martin EL, Martin RD, Massarczyk R, Meijer SJ, Mertens S, Oli TK, Othman G, Paudel LS, Pettus W, Poon AWP, Radford DC, Reine AL, Rielage K, Ruof NW, Schaper DC, Tedeschi D, Varner RL, Vasilyev S, Wilkerson JF, Wiseman C, Xu W, Yu CH, Zhu BX. Final Result of the Majorana Demonstrator's Search for Neutrinoless Double-β Decay in ^{76}Ge. Phys Rev Lett 2023; 130:062501. [PMID: 36827565 DOI: 10.1103/physrevlett.130.062501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 11/09/2022] [Accepted: 12/16/2022] [Indexed: 06/18/2023]
Abstract
The Majorana Demonstrator searched for neutrinoless double-β decay (0νββ) of ^{76}Ge using modular arrays of high-purity Ge detectors operated in vacuum cryostats in a low-background shield. The arrays operated with up to 40.4 kg of detectors (27.2 kg enriched to ∼88% in ^{76}Ge). From these measurements, the Demonstrator has accumulated 64.5 kg yr of enriched active exposure. With a world-leading energy resolution of 2.52 keV FWHM at the 2039 keV Q_{ββ} (0.12%), we set a half-life limit of 0νββ in ^{76}Ge at T_{1/2}>8.3×10^{25} yr (90% C.L.). This provides a range of upper limits on m_{ββ} of (113-269) meV (90% C.L.), depending on the choice of nuclear matrix elements.
Collapse
Affiliation(s)
- I J Arnquist
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - A S Barabash
- National Research Center "Kurchatov Institute" Institute for Theoretical and Experimental Physics, Moscow, 117218 Russia
| | - C J Barton
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - P J Barton
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - K H Bhimani
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - E Blalock
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - B Bos
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - M Busch
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - M Buuck
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - T S Caldwell
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - Y-D Chan
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - P-H Chu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M L Clark
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Cuesta
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, CIEMAT, 28040 Madrid, Spain
| | - J A Detwiler
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - Yu Efremenko
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37916, USA
| | - H Ejiri
- Research Center for Nuclear Physics, Osaka University, Ibaraki, Osaka 567-0047, Japan
| | - S R Elliott
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - G K Giovanetti
- Physics Department, Williams College, Williamstown, Massachusetts 01267, USA
| | - M P Green
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - J Gruszko
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - I S Guinn
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - V E Guiseppe
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - C R Haufe
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R Henning
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - D Hervas Aguilar
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - E W Hoppe
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - A Hostiuc
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - M F Kidd
- Tennessee Tech University, Cookeville, Tennessee 38505, USA
| | - I Kim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - R T Kouzes
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - T E Lannen V
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A Li
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - A M Lopez
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37916, USA
| | | | - E L Martin
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R D Martin
- Department of Physics, Engineering Physics and Astronomy, Queen's University, Kingston, Ontario K7L 3N6, Canada
| | - R Massarczyk
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S J Meijer
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S Mertens
- Max-Planck-Institut für Physik, München 80805, Germany
- Physik Department and Excellence Cluster Universe, Technische Universität, München, 85748 Germany
| | - T K Oli
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - G Othman
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - L S Paudel
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - W Pettus
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- IU Center for Exploration of Energy and Matter, Bloomington, Indiana 47408, USA
| | - A W P Poon
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - D C Radford
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - A L Reine
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - K Rielage
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - N W Ruof
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - D C Schaper
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D Tedeschi
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - R L Varner
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - S Vasilyev
- Joint Institute for Nuclear Research, Dubna, 141980 Russia
| | - J F Wilkerson
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Wiseman
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - W Xu
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - C-H Yu
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - B X Zhu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| |
Collapse
|
15
|
Moon Y, Lee S, Lee J, Kim S, Kim I, Joo W, Jung S, Choi M, Park H, Lee C, Chung YG, Kim K, Park Y, Seong R. OD2-4 Efficient and noninvasive T cell therapy platform using autologous peripheral blood PD-1+CD8+ T cells instead of tumor-infiltrating lymphocytes in solid tumors: Ex vivo efficacy. ESMO Open 2022. [DOI: 10.1016/j.esmoop.2022.100668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
|
16
|
Muhizi S, Kim I. Microbial agent spraying in pig housing and slurry can potentially
reduce harmful gas emissions – a preliminary study. J Anim Feed Sci 2022. [DOI: 10.22358/jafs/154037/2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
17
|
Boshra M, Lee A, Kim I, Malek-Adamian E, Yau M, LaDonna KA. When patients teach students empathy: a systematic review of interventions for promoting medical student empathy. Can Med Educ J 2022; 13:46-56. [PMID: 36440084 PMCID: PMC9684039 DOI: 10.36834/cmej.73058] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
BACKGROUND Despite growing emphasis on empathic care, numerous studies demonstrate diminishing empathy in medical students. Involving patient educators in medical curricula may be a solution. Therefore, we conducted a systematic review to evaluate patient-involved interventions that promote empathy among medical students. METHOD A literature search of MEDLINE, Embase, PsycINFO, and ERIC databases was performed using the keywords "empathy," "medical student," and their synonyms. Results were independently screened in duplicate. Conflicts were resolved by group consensus. All English studies describing interventions that promote empathy in medical students engaging patient educators were included. Relevant data was extracted and summarized. RESULTS 1467 studies were screened. 14 studies were included, of which 10 were pilot studies. Studies included patient involved interventions such as storytelling (5/14), shadowing patients (3/14), recorded videos (3/14), or combinations of methods (3/14). Qualitative measurements of empathy included written feedback and group discussions. Quantitative measurements included validated scales measuring empathy. All studies demonstrated increase in empathy among medical students. Participants reported satisfaction with training and patients reported being proud of giving back by training future physicians. CONCLUSION Interventions engaging patient educators were shown to have a positive impact on medical student empathy. Furthermore, patient-led education was shown to increase medical student understanding of subject and knowledge retention while empowering patients. Further implementation of patient-involved education is an important step forward in patient-partnered care and may identify additional advantages of patient engagement in medical education.
Collapse
Affiliation(s)
- M Boshra
- Faculty of Medicine, University of Ottawa, Ontario, Canada
| | - A Lee
- Faculty of Medicine, University of Ottawa, Ontario, Canada
| | - I Kim
- Faculty of Medicine, University of Ottawa, Ontario, Canada
| | | | - M Yau
- Faculty of Medicine, University of Ottawa, Ontario, Canada
| | - KA LaDonna
- Faculty of Medicine, University of Ottawa, Ontario, Canada
- Department of Innovation in Medical Education and Department of Medicine, University of Ottawa, Ontario, Canada
| |
Collapse
|
18
|
Jeon S, Ha JH, Kim I, Bae J, Kim SW. The Immunomodulatory Effect of Adipose-Derived Stem Cells in Xenograft Transplantation Model. Transplant Proc 2022; 54:2388-2395. [PMID: 36184343 DOI: 10.1016/j.transproceed.2022.06.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Revised: 05/09/2022] [Accepted: 06/16/2022] [Indexed: 10/14/2022]
Abstract
Adipose-derived stem cells (ASCs) have demonstrated immunomodulatory and anti-inflammatory effects in preclinical studies. The purpose of this study was to evaluate the effects of ASCs on the survival of xenogeneic full-thickness skin grafts and compare intravenous and subcutaneous injections of ASCs. We divided 30 male C57BL/6 mice into control, intravenous (IV), and subcutaneous (SC) injection groups. In one group of 10 mice, mouse ASCs were intravenously injected after human full-thickness skin grafting (IV group). In another group of 10 mice, ASCs were directly injected into the subcutaneous plane under the xenogeneic grafts (SC group). An additional group of 10 mice received no treatment and served as controls. Bioluminescent imaging showed that ASCs were concentrated at the grafts during the study period in both IV and SC groups. We performed graft survival assessment, histologic examination, and immunohistochemistry analysis. ASCs significantly prolonged xenograft survival at postoperative week 2 in the SC group compared with the control group (P < .05). Histologic evaluation revealed fewer inflammatory reactions in the SC group than in the control group at 1 week posttransplantation. In addition, we observed relative reduction in CD4- and CD8-positive cells in the SC group compared with the control group. Intravenous injection of ASCs led to increased graft survival and decreased inflammatory reactions, but these differences were not statistically significant. The results of this study indicate that subcutaneous injection of ASCs promoted the survival of xenogeneic full-thickness skin grafts in mice. The underlying mechanisms of the immunosuppressive effects of ASCs should be further investigated.
Collapse
Affiliation(s)
- Sungmi Jeon
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Jeong Hyun Ha
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Iljin Kim
- Department of Pharmacology, Inha University College of Medicine, Incheon, Republic of Korea
| | - Jiyoon Bae
- Department of Pathology, National Police Hospital, Seoul, Republic of Korea
| | - Sang Wha Kim
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
| |
Collapse
|
19
|
Ajani J, Sharpe D, De T, Kim I, Gricar J, Kurt M. 1218P Long-term survivorship rates among chemotherapy refractory or intolerant advanced esophageal squamous cell carcinoma (aESCC) patients treated with nivolumab (NIVO). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
20
|
Yoo C, Kim KP, Kim I, Kang M, Cheon J, Kang B, Ryu H, Jeong J, Lee J, Kim K, Ryoo BY, Abou-Alfa G. 55P Final results from the NIFTY trial, a phase IIb, randomized, open-label study of liposomal Irinotecan (nal-IRI) plus fluorouracil (5-FU)/leucovorin (LV) in patients (pts) with previously treated metastatic biliary tract cancer (BTC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.083] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
21
|
Arnquist IJ, Avignone FT, Barabash AS, Barton CJ, Bhimani KH, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Chan YD, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Efremenko Y, Ejiri H, Elliott SR, Giovanetti GK, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Henning R, Hervas Aguilar D, Hoppe EW, Hostiuc A, Kim I, Kouzes RT, Lannen V TE, Li A, Lopez AM, López-Castaño JM, Martin EL, Martin RD, Massarczyk R, Meijer SJ, Oli TK, Othman G, Paudel LS, Pettus W, Poon AWP, Radford DC, Reine AL, Rielage K, Ruof NW, Tedeschi D, Varner RL, Vasilyev S, Wilkerson JF, Wiseman C, Xu W, Yu CH, Zhu BX. Search for Spontaneous Radiation from Wave Function Collapse in the Majorana Demonstrator. Phys Rev Lett 2022; 129:080401. [PMID: 36053678 DOI: 10.1103/physrevlett.129.080401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/02/2022] [Revised: 06/14/2022] [Accepted: 07/15/2022] [Indexed: 06/15/2023]
Abstract
The Majorana Demonstrator neutrinoless double-beta decay experiment comprises a 44 kg (30 kg enriched in ^{76}Ge) array of p-type, point-contact germanium detectors. With its unprecedented energy resolution and ultralow backgrounds, Majorana also searches for rare event signatures from beyond standard model physics in the low energy region below 100 keV. In this Letter, we test the continuous spontaneous localization (CSL) model, one of the mathematically well-motivated wave function collapse models aimed at solving the long-standing unresolved quantum mechanical measurement problem. While the CSL predicts the existence of a detectable radiation signature in the x-ray domain, we find no evidence of such radiation in the 19-100 keV range in a 37.5 kg-y enriched germanium exposure collected between December 31, 2015, and November 27, 2019, with the Demonstrator. We explored both the non-mass-proportional (n-m-p) and the mass-proportional (m-p) versions of the CSL with two different assumptions: that only the quasifree electrons can emit the x-ray radiation and that the nucleus can coherently emit an amplified radiation. In all cases, we set the most stringent upper limit to date for the white CSL model on the collapse rate, λ, providing a factor of 40-100 improvement in sensitivity over comparable searches. Our limit is the most stringent for large parts of the allowed parameter space. If the result is interpreted in terms of the Diòsi-Penrose gravitational wave function collapse model, the lower bound with a 95% confidence level is almost an order of magnitude improvement over the previous best limit.
Collapse
Affiliation(s)
- I J Arnquist
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - A S Barabash
- National Research Center "Kurchatov Institute" Institute for Theoretical and Experimental Physics, Moscow, 117218 Russia
| | - C J Barton
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - K H Bhimani
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - E Blalock
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - B Bos
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - M Busch
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - M Buuck
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - T S Caldwell
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - Y-D Chan
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - P-H Chu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M L Clark
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Cuesta
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, CIEMAT 28040 Madrid, Spain
| | - J A Detwiler
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - Yu Efremenko
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37916, USA
| | - H Ejiri
- Research Center for Nuclear Physics, Osaka University, Ibaraki, Osaka 567-0047, Japan
| | - S R Elliott
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - G K Giovanetti
- Physics Department, Williams College, Williamstown, Massachusetts 01267, USA
| | - M P Green
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - J Gruszko
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - I S Guinn
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - V E Guiseppe
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - C R Haufe
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R Henning
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - D Hervas Aguilar
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - E W Hoppe
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - A Hostiuc
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - I Kim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - R T Kouzes
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - T E Lannen V
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A Li
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - A M Lopez
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37916, USA
| | | | - E L Martin
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R D Martin
- Department of Physics, Engineering Physics and Astronomy, Queen's University, Kingston, Ontario K7L 3N6, Canada
| | - R Massarczyk
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S J Meijer
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - T K Oli
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - G Othman
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - L S Paudel
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - W Pettus
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- IU Center for Exploration of Energy and Matter, Bloomington, Indiana 47408, USA
| | - A W P Poon
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - D C Radford
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - A L Reine
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - K Rielage
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - N W Ruof
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - D Tedeschi
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - R L Varner
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - S Vasilyev
- Joint Institute for Nuclear Research, Dubna, 141980 Russia
| | - J F Wilkerson
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Wiseman
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - W Xu
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - C-H Yu
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - B X Zhu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| |
Collapse
|
22
|
Arnquist IJ, Avignone FT, Barabash AS, Barton CJ, Bhimani KH, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Chan YD, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Efremenko Y, Ejiri H, Elliott SR, Giovanetti GK, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Henning R, Hervas Aguilar D, Hoppe EW, Hostiuc A, Kidd MF, Kim I, Kouzes RT, Lannen V TE, Li A, Lopez AM, López-Castaño JM, Martin EL, Martin RD, Massarczyk R, Meijer SJ, Oli TK, Othman G, Paudel LS, Pettus W, Poon AWP, Radford DC, Reine AL, Rielage K, Ruof NW, Schaper DC, Tedeschi D, Varner RL, Vasilyev S, Wilkerson JF, Wiseman C, Xu W, Yu CH, Zhu BX. Search for Solar Axions via Axion-Photon Coupling with the Majorana Demonstrator. Phys Rev Lett 2022; 129:081803. [PMID: 36053699 DOI: 10.1103/physrevlett.129.081803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2022] [Accepted: 07/21/2022] [Indexed: 06/15/2023]
Abstract
Axions were originally proposed to explain the strong-CP problem in QCD. Through axion-photon coupling, the Sun could be a major source of axions, which could be measured in solid state detection experiments with enhancements due to coherent Primakoff-Bragg scattering. The Majorana Demonstrator experiment has searched for solar axions with a set of ^{76}Ge-enriched high purity germanium detectors using a 33 kg-yr exposure collected between January, 2017 and November, 2019. A temporal-energy analysis gives a new limit on the axion-photon coupling as g_{aγ}<1.45×10^{-9} GeV^{-1} (95% confidence level) for axions with mass up to 100 eV/c^{2}. This improves laboratory-based limits between about 1 eV/c^{2} and 100 eV/c^{2}.
Collapse
Affiliation(s)
- I J Arnquist
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - A S Barabash
- National Research Center "Kurchatov Institute" Institute for Theoretical and Experimental Physics, Moscow, 117218 Russia
| | - C J Barton
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - K H Bhimani
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - E Blalock
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - B Bos
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - M Busch
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - M Buuck
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - T S Caldwell
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - Y-D Chan
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - P-H Chu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M L Clark
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Cuesta
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, CIEMAT 28040, Madrid, Spain
| | - J A Detwiler
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - Yu Efremenko
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37916, USA
| | - H Ejiri
- Research Center for Nuclear Physics, Osaka University, Ibaraki, Osaka 567-0047, Japan
| | - S R Elliott
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - G K Giovanetti
- Physics Department, Williams College, Williamstown, Massachusetts 01267, USA
| | - M P Green
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - J Gruszko
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - I S Guinn
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - V E Guiseppe
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - C R Haufe
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R Henning
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - D Hervas Aguilar
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - E W Hoppe
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - A Hostiuc
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - M F Kidd
- Tennessee Tech University, Cookeville, Tennessee 38505, USA
| | - I Kim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - R T Kouzes
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - T E Lannen V
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A Li
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - A M Lopez
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37916, USA
| | | | - E L Martin
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R D Martin
- Department of Physics, Engineering Physics and Astronomy, Queen's University, Kingston, Ontario K7L 3N6, Canada
| | - R Massarczyk
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S J Meijer
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - T K Oli
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - G Othman
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - L S Paudel
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - W Pettus
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- IU Center for Exploration of Energy and Matter, Bloomington, Indiana 47408, USA
| | - A W P Poon
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - D C Radford
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - A L Reine
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - K Rielage
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - N W Ruof
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - D C Schaper
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D Tedeschi
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - R L Varner
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - S Vasilyev
- Joint Institute for Nuclear Research, Dubna, 141980 Russia
| | - J F Wilkerson
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27514, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Wiseman
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - W Xu
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - C-H Yu
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - B X Zhu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| |
Collapse
|
23
|
Klosowicz A, Crouch J, Zhan Q, Kim I, Gehad A, Teague J, Kupper T, Clark R. 085 Senescent dendritic cells drive ROS-induced DNA damage in CTCL. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
24
|
Wahid S, Lee B, Kim I. Effect of purified docosahexaenoic acid supplementation
on production performance, meat quality,
and intestinal microbiome of finishing pigs. J Anim Feed Sci 2022. [DOI: 10.22358/jafs/150033/2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
25
|
Kim I, Choi S, Yoo S, Lee M, Kim IS. Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment. Cancers (Basel) 2022; 14:cancers14143321. [PMID: 35884382 PMCID: PMC9320406 DOI: 10.3390/cancers14143321] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Revised: 06/30/2022] [Accepted: 07/05/2022] [Indexed: 02/04/2023] Open
Abstract
Simple Summary Cancers have regions of low oxygen concentration where hypoxia-related signaling pathways are activated. The hypoxic tumor microenvironment has been widely accepted as a hallmark of cancer and shown to be a critical factor in the crosstalk between cancer and stromal cells. Fibroblasts are one of the most abundant cellular components in the tumor stroma and are also significantly affected by oxygen deprivation. In this case, we discuss the molecular and cellular mechanisms that regulate fibroblasts under hypoxic conditions and their effect on cancer development and progression. Unraveling these regulatory mechanisms could be exploited in developing potential fibroblast-specific therapeutics for cancer. Abstract Solid cancers are composed of malignant cells and their surrounding matrix components. Hypoxia plays a critical role in shaping the tumor microenvironment that contributes to cancer progression and treatment failure. Cancer-associated fibroblasts (CAFs) are one of the most prominent components of the tumor microenvironment. CAFs are highly sensitive to hypoxia and participates in the crosstalk with cancer cells. Hypoxic CAFs modulate several mechanisms that induce cancer malignancy, such as extracellular matrix (ECM) remodeling, immune evasion, metabolic reprogramming, angiogenesis, metastasis, and drug resistance. Key signaling molecules regulating CAFs in hypoxia include transforming growth factor (TGF-β) and hypoxia-inducible factors (HIFs). In this article, we summarize the mechanisms underlying the hypoxic regulation of CAFs and how hypoxic CAFs affect cancer development and progression. We also discuss the potential therapeutic strategies focused on targeting CAFs in the hypoxic tumor microenvironment.
Collapse
Affiliation(s)
- Iljin Kim
- Department of Pharmacology and Research Center for Controlling Intercellular Communication, Inha University College of Medicine, Incheon 22212, Korea; (S.C.); (S.Y.)
- Correspondence: (I.K.); (I.-S.K.)
| | - Sanga Choi
- Department of Pharmacology and Research Center for Controlling Intercellular Communication, Inha University College of Medicine, Incheon 22212, Korea; (S.C.); (S.Y.)
| | - Seongkyeong Yoo
- Department of Pharmacology and Research Center for Controlling Intercellular Communication, Inha University College of Medicine, Incheon 22212, Korea; (S.C.); (S.Y.)
| | - Mingyu Lee
- Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA;
| | - In-San Kim
- KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Korea
- Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute Science and Technology, Seoul 02792, Korea
- Correspondence: (I.K.); (I.-S.K.)
| |
Collapse
|
26
|
Abstract
The acute response to hypoxia is mainly driven by hypoxia-inducible factors, but their effects gradually subside with time. Hypoxia-specific histone modifications may be important for the stable maintenance of long-term adaptation to hypoxia. However, little is known about the molecular mechanisms underlying the dynamic alterations of histones under hypoxic conditions. We found that the phosphorylation of histone H3 at Ser-10 (H3S10) was noticeably attenuated after hypoxic challenge, which was mediated by the inhibition of aurora kinase B (AURKB). To understand the role of AURKB in epigenetic regulation, DNA microarray and transcription factor binding site analyses combined with proteomics analysis were performed. Under normoxia, phosphorylated AURKB, in concert with the repressor element-1 silencing transcription factor (REST), phosphorylates H3S10, which allows the AURKB–REST complex to access the MDM2 proto-oncogene. REST then acts as a transcriptional repressor of MDM2 and downregulates its expression. Under hypoxia, AURKB is dephosphorylated and the AURKB–REST complex fails to access MDM2, leading to the upregulation of its expression. In this study, we present a case of hypoxia-specific epigenetic regulation of the oxygen-sensitive AURKB signaling pathway. To better understand the cellular adaptation to hypoxia, it is worthwhile to further investigate the epigenetic regulation of genes under hypoxic conditions.
Collapse
Affiliation(s)
- Iljin Kim
- Department of Pharmacology, Inha University College of Medicine, Incheon 22212, Korea
| | - Sanga Choi
- Department of Pharmacology, Inha University College of Medicine, Incheon 22212, Korea
| | - Seongkyeong Yoo
- Department of Pharmacology, Inha University College of Medicine, Incheon 22212, Korea
| | - Mingyu Lee
- Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston 02115, MA, USA
| | - Jong-Wan Park
- Department of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea
- Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea
| |
Collapse
|
27
|
Barinov VV, Cleveland BT, Danshin SN, Ejiri H, Elliott SR, Frekers D, Gavrin VN, Gorbachev VV, Gorbunov DS, Haxton WC, Ibragimova TV, Kim I, Kozlova YP, Kravchuk LV, Kuzminov VV, Lubsandorzhiev BK, Malyshkin YM, Massarczyk R, Matveev VA, Mirmov IN, Nico JS, Petelin AL, Robertson RGH, Sinclair D, Shikhin AA, Tarasov VA, Trubnikov GV, Veretenkin EP, Wilkerson JF, Zvir AI. Results from the Baksan Experiment on Sterile Transitions (BEST). Phys Rev Lett 2022; 128:232501. [PMID: 35749172 DOI: 10.1103/physrevlett.128.232501] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Revised: 01/18/2022] [Accepted: 02/28/2022] [Indexed: 06/15/2023]
Abstract
The Baksan Experiment on Sterile Transitions (BEST) was designed to investigate the deficit of electron neutrinos ν_{e} observed in previous gallium-based radiochemical measurements with high-intensity neutrino sources, commonly referred to as the "gallium anomaly," which could be interpreted as evidence for oscillations between ν_{e} and sterile neutrino (ν_{s}) states. A 3.414-MCi ^{51}Cr ν_{e} source was placed at the center of two nested Ga volumes and measurements were made of the production of ^{71}Ge through the charged current reaction, ^{71}Ga(ν_{e},e^{-})^{71}Ge, at two average distances. The measured production rates for the inner and the outer targets, respectively, are [54.9_{-2.4}^{+2.5}(stat)±1.4(syst)] and [55.6_{-2.6}^{+2.7}(stat)±1.4(syst)] atoms of ^{71}Ge/d. The ratio (R) of the measured rate of ^{71}Ge production at each distance to the expected rate from the known cross section and experimental efficiencies are R_{in}=0.79±0.05 and R_{out}=0.77±0.05. The ratio of the outer to the inner result is 0.97±0.07, which is consistent with unity within uncertainty. The rates at each distance were found to be similar, but 20%-24% lower than expected, thus reaffirming the anomaly. These results are consistent with ν_{e}→ν_{s} oscillations with a relatively large Δm^{2} (>0.5 eV^{2}) and mixing sin^{2}2θ (≈0.4).
Collapse
Affiliation(s)
- V V Barinov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | | | - S N Danshin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - H Ejiri
- Research Center for Nuclear Physics, Osaka University, Osaka 567-0047, Japan
| | - S R Elliott
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D Frekers
- Institut für Kernphysik, Westfälische Wilhelms-Universität Munster, D-48149 Munster, Germany
| | - V N Gavrin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - V V Gorbachev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - D S Gorbunov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - W C Haxton
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - T V Ibragimova
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - I Kim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - Yu P Kozlova
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - L V Kravchuk
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - V V Kuzminov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - B K Lubsandorzhiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - Yu M Malyshkin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - R Massarczyk
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - V A Matveev
- Joint Institute for Nuclear Research (JINR) Joliot-Curie 6, 141980 Dubna, Moscow Region, Russia
| | - I N Mirmov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - J S Nico
- National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, Maryland 20899, USA
| | - A L Petelin
- JSC "State Scientific Center Research Institute of Atomic Reactors," Dimitrovgrad 433510, Russia
| | - R G H Robertson
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - D Sinclair
- Carleton University 1125 Colonel By Drive, Ottawa K1S 5B6, Canada
| | - A A Shikhin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - V A Tarasov
- JSC "State Scientific Center Research Institute of Atomic Reactors," Dimitrovgrad 433510, Russia
| | - G V Trubnikov
- Joint Institute for Nuclear Research (JINR) Joliot-Curie 6, 141980 Dubna, Moscow Region, Russia
| | - E P Veretenkin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow 117312, Russia
| | - J F Wilkerson
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27599, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - A I Zvir
- JSC "State Scientific Center Research Institute of Atomic Reactors," Dimitrovgrad 433510, Russia
| |
Collapse
|
28
|
Kwak SB, Kim SJ, Kim J, Kang YL, Ko CW, Kim I, Park JW. Tumor regionalization after surgery: Roles of the tumor microenvironment and neutrophil extracellular traps. Exp Mol Med 2022; 54:720-729. [PMID: 35764882 PMCID: PMC9256747 DOI: 10.1038/s12276-022-00784-2] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/16/2022] [Revised: 03/20/2022] [Accepted: 03/30/2022] [Indexed: 11/09/2022]
Abstract
Surgery is unanimously regarded as the primary strategy to cure solid tumors in the early stages but is not always used in advanced cases. However, tumor surgery must be carefully considered because the risk of metastasis could be increased by the surgical procedure. Tumor surgery may result in a deep wound, which induces many biological responses favoring tumor metastasis. In particular, NETosis, which is the process of forming neutrophil extracellular traps (NETs), has received attention as a risk factor for surgery-induced metastasis. To reduce cancer mortality, researchers have made efforts to prevent secondary metastasis after resection of the primary tumor. From this point of view, a better understanding of surgery-induced metastasis might provide new strategies for more effective and safer surgical approaches. In this paper, recent insights into the surgical effects on metastasis will be reviewed. Moreover, in-depth opinions about the effects of NETs on metastasis will be discussed. Therapies that limit the formation of web-like structures formed by white cells known as neutrophils may lower the risk of cancer spread (metastasis) following surgical tumor removal. Removing solid tumors remains a key cancer treatment, but in some cases surgery itself increases the risk of metastasis. Jong-Wan Park at Seoul National University, South Korea, and co-workers reviewed current understanding of metastasis following surgery. Surgical removal destroys the architecture supporting cancer cells but this can release tumor cells into blood vessels. The stress of deep wounds also affects immune responses, most notably neutrophil extracellular traps (NETs), web-like structures formed by neutrophils to trap and kill pathogens. NETs have previously been implicated in metastasis. In a post-surgical environment enriched in neutrophils and pro-inflammatory cytokines, NET formation may help cancer cells thrive, promoting metastasis.
Collapse
Affiliation(s)
- Su-Bin Kwak
- Department of Pharmacology, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea.,Department of Biomedical Science, BK21-plus Education Program, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
| | - Sang Jin Kim
- Department of Pharmacology, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea.,Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
| | - Jiyoung Kim
- Department of Pharmacology, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
| | - Ye-Lim Kang
- Department of Pharmacology, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea.,Department of Biomedical Science, BK21-plus Education Program, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
| | - Chang Woo Ko
- Department of Pharmacology, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea.,Department of Biomedical Science, BK21-plus Education Program, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
| | - Iljin Kim
- Department of Pharmacology, Inha University College of Medicine, Inha-ro, Michuhol-gu, Incheon, 22212, Korea
| | - Jong-Wan Park
- Department of Pharmacology, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea. .,Department of Biomedical Science, BK21-plus Education Program, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea. .,Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
| |
Collapse
|
29
|
Alagoz O, Ajani J, Srinivasan S, Kim I, Singh P, Xiao H, Kurt M. P-56 Estimating endpoint correlation between surrogate measures and overall survival using reconstructed survival data: Case studies from adjuvant and metastatic gastric cancer trials. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
30
|
Lee S, Dong-Won Y, Cheon J, Lee S, Cho H, Kim I. M231 Application trial of moving average as a tool of realtime quality control of clinical chemistry. Clin Chim Acta 2022. [DOI: 10.1016/j.cca.2022.04.419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
31
|
Arnquist IJ, Avignone FT, Barabash AS, Barton CJ, Bertrand FE, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Chan YD, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Drobizhev A, Edwards TR, Edwins DW, Edzards F, Efremenko Y, Elliott SR, Gilliss T, Giovanetti GK, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Hegedus RJ, Henning R, Aguilar DH, Hoppe EW, Hostiuc A, Kim I, Kouzes RT, Lopez AM, López-Castaño JM, Martin EL, Martin RD, Massarczyk R, Meijer SJ, Mertens S, Myslik J, Oli TK, Othman G, Pettus W, Poon AWP, Radford DC, Rager J, Reine AL, Rielage K, Ruof NW, Saykı B, Schönert S, Stortini MJ, Tedeschi D, Varner RL, Vasilyev S, Wilkerson JF, Willers M, Wiseman C, Xu W, Yu CH, Zhu BX. α -event characterization and rejection in point-contact HPGe detectors. Eur Phys J C Part Fields 2022; 82:226. [PMID: 35310515 PMCID: PMC8921096 DOI: 10.1140/epjc/s10052-022-10161-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Accepted: 02/23/2022] [Indexed: 06/14/2023]
Abstract
P-type point contact (PPC) HPGe detectors are a leading technology for rare event searches due to their excellent energy resolution, low thresholds, and multi-site event rejection capabilities. We have characterized a PPC detector's response to α particles incident on the sensitive passivated and p + surfaces, a previously poorly-understood source of background. The detector studied is identical to those in the Majorana Demonstrator experiment, a search for neutrinoless double-beta decay ( 0 ν β β ) in 76 Ge. α decays on most of the passivated surface exhibit significant energy loss due to charge trapping, with waveforms exhibiting a delayed charge recovery (DCR) signature caused by the slow collection of a fraction of the trapped charge. The DCR is found to be complementary to existing methods of α identification, reliably identifying α background events on the passivated surface of the detector. We demonstrate effective rejection of all surface α events (to within statistical uncertainty) with a loss of only 0.2% of bulk events by combining the DCR discriminator with previously-used methods. The DCR discriminator has been used to reduce the background rate in the 0 ν β β region of interest window by an order of magnitude in the Majorana Demonstrator and will be used in the upcoming LEGEND-200 experiment.
Collapse
Affiliation(s)
- I. J. Arnquist
- Pacific Northwest National Laboratory, Richland, WA 99354 USA
| | - F. T. Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, SC 29208 USA
- Oak Ridge National Laboratory, Oak Ridge, TN 37830 USA
| | - A. S. Barabash
- National Research Center “Kurchatov Institute” Institute for Theoretical and Experimental Physics, Moscow, 117218 Russia
| | - C. J. Barton
- Department of Physics, University of South Dakota, Vermillion, SD 57069 USA
| | | | - E. Blalock
- Department of Physics, North Carolina State University, Raleigh, NC 27695 USA
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
| | - B. Bos
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - M. Busch
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics, Duke University, Durham, NC 27708 USA
| | - M. Buuck
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, WA 98195 USA
- Present Address: SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - T. S. Caldwell
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - Y.-D. Chan
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - P.-H. Chu
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - M. L. Clark
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - C. Cuesta
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, WA 98195 USA
- Present Address: Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, CIEMAT, 28040 Madrid Spain
| | - J. A. Detwiler
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, WA 98195 USA
| | - A. Drobizhev
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - T. R. Edwards
- Department of Physics, University of South Dakota, Vermillion, SD 57069 USA
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - D. W. Edwins
- Department of Physics and Astronomy, University of South Carolina, Columbia, SC 29208 USA
| | - F. Edzards
- Max-Planck-Institut für Physik, 80805 Munich, Germany
- Present Address: Physik-Department, Technische Universität, 85748 Munich, Germany
| | - Y. Efremenko
- Oak Ridge National Laboratory, Oak Ridge, TN 37830 USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, TN 37916 USA
| | - S. R. Elliott
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - T. Gilliss
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
- Present Address: Applied Physics Laboratory, Johns Hopkins University, Laurel, MD 20723 USA
| | - G. K. Giovanetti
- Physics Department, Williams College, Williamstown, MA 01267 USA
| | - M. P. Green
- Oak Ridge National Laboratory, Oak Ridge, TN 37830 USA
- Department of Physics, North Carolina State University, Raleigh, NC 27695 USA
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
| | - J. Gruszko
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - I. S. Guinn
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | | | - C. R. Haufe
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - R. J. Hegedus
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - R. Henning
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - D. Hervas Aguilar
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - E. W. Hoppe
- Pacific Northwest National Laboratory, Richland, WA 99354 USA
| | - A. Hostiuc
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, WA 98195 USA
| | - I. Kim
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - R. T. Kouzes
- Pacific Northwest National Laboratory, Richland, WA 99354 USA
| | - A. M. Lopez
- Department of Physics and Astronomy, University of Tennessee, Knoxville, TN 37916 USA
| | | | - E. L. Martin
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics, Duke University, Durham, NC 27708 USA
| | - R. D. Martin
- Department of Physics, Engineering Physics and Astronomy, Queen’s University, Kingston, ON K7L 3N6 Canada
| | - R. Massarczyk
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - S. J. Meijer
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - S. Mertens
- Max-Planck-Institut für Physik, 80805 Munich, Germany
- Present Address: Physik-Department, Technische Universität, 85748 Munich, Germany
| | - J. Myslik
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - T. K. Oli
- Department of Physics, University of South Dakota, Vermillion, SD 57069 USA
| | - G. Othman
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
- Universität Hamburg, 20146 Hamburg, Germany
| | - W. Pettus
- Department of Physics, Indiana University, Bloomington, IN 47405 USA
- IU Center for Exploration of Energy and Matter, Bloomington, IN 47408 USA
| | - A. W. P. Poon
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - D. C. Radford
- Oak Ridge National Laboratory, Oak Ridge, TN 37830 USA
| | - J. Rager
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
- Present Address: Applied Research Associated, Raleigh, NC 27615 USA
| | - A. L. Reine
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - K. Rielage
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - N. W. Ruof
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, WA 98195 USA
| | - B. Saykı
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - S. Schönert
- Present Address: Physik-Department, Technische Universität, 85748 Munich, Germany
| | - M. J. Stortini
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - D. Tedeschi
- Department of Physics and Astronomy, University of South Carolina, Columbia, SC 29208 USA
| | - R. L. Varner
- Oak Ridge National Laboratory, Oak Ridge, TN 37830 USA
| | - S. Vasilyev
- Joint Institute for Nuclear Research, Dubna, 141980 Russia
| | - J. F. Wilkerson
- Oak Ridge National Laboratory, Oak Ridge, TN 37830 USA
- Triangle Universities Nuclear Laboratory, Durham, NC 27708 USA
- Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27514 USA
| | - M. Willers
- Present Address: Physik-Department, Technische Universität, 85748 Munich, Germany
| | - C. Wiseman
- Center for Experimental Nuclear Physics and Astrophysics, and Department of Physics, University of Washington, Seattle, WA 98195 USA
| | - W. Xu
- Department of Physics, University of South Dakota, Vermillion, SD 57069 USA
| | - C.-H. Yu
- Oak Ridge National Laboratory, Oak Ridge, TN 37830 USA
| | - B. X. Zhu
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
- Present Address: Jet Propulsion Laboratory, California Institute of Technology, Pasadena, CA 91109 USA
| |
Collapse
|
32
|
Lee M, Lim S, Kim YS, Khalmuratova R, Shin SH, Kim I, Kim HJ, Kim DY, Rhee CS, Park JW, Shin HW. DEP-induced ZEB2 promotes nasal polyp formation via epithelial-to-mesenchymal transition. J Allergy Clin Immunol 2022; 149:340-357. [PMID: 33957165 DOI: 10.1016/j.jaci.2021.04.024] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Revised: 04/08/2021] [Accepted: 04/16/2021] [Indexed: 12/20/2022]
Abstract
BACKGROUND Diesel exhaust particles (DEPs) are associated with the prevalence and exacerbation of allergic respiratory diseases, including allergic rhinitis and allergic asthma. However, DEP-induced mechanistic pathways promoting upper airway disease and their clinical implications remain unclear. OBJECTIVE We sought to investigate the mechanisms by which DEP exposure contributes to nasal polyposis using human-derived epithelial cells and a murine nasal polyp (NP) model. METHODS Gene set enrichment and weighted gene coexpression network analyses were performed. Cytotoxicity, epithelial-to-mesenchymal transition (EMT) markers, and nasal polyposis were assessed. Effects of DEP exposure on EMT were determined using epithelial cells from normal people or patients with chronic rhinosinusitis with or without NPs. BALB/c mice were exposed to DEP through either a nose-only exposure system or nasal instillation, with or without house dust mite, followed by zinc finger E-box-binding homeobox (ZEB)2 small hairpin RNA delivery. RESULTS Bioinformatics analyses revealed that DEP exposure triggered EMT features in airway epithelial cells. Similarly, DEP-exposed human nasal epithelial cells exhibited EMT characteristics, which were dependent on ZEB2 expression. Human nasal epithelial cells derived from patients with chronic rhinosinusitis presented more prominent EMT features after DEP treatment, when compared with those from control subjects and patients with NPs. Coexposure to DEP and house dust mite synergistically increased the number of NPs, epithelial disruptions, and ZEB2 expression. Most importantly, ZEB2 inhibition prevented DEP-induced EMT, thereby alleviating NP formation in mice. CONCLUSIONS Our data show that DEP facilitated NP formation, possibly via the promotion of ZEB2-induced EMT. ZEB2 may be a therapeutic target for DEP-induced epithelial damage and related airway diseases, including NPs.
Collapse
Affiliation(s)
- Mingyu Lee
- Obstructive Upper airway Research Laboratory, the Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School, Boston, Mass
| | - Suha Lim
- Obstructive Upper airway Research Laboratory, the Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
| | - Yi Sook Kim
- Obstructive Upper airway Research Laboratory, the Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
| | - Roza Khalmuratova
- Obstructive Upper airway Research Laboratory, the Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea
| | - Seung-Hyun Shin
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
| | - Iljin Kim
- Department of Pharmacology, Inha University College of Medicine, Incheon, Korea
| | - Hyun-Jik Kim
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Korea
| | - Dong-Young Kim
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Korea
| | - Chae-Seo Rhee
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Korea
| | - Jong-Wan Park
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea
| | - Hyun-Woo Shin
- Obstructive Upper airway Research Laboratory, the Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Korea; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea.
| |
Collapse
|
33
|
Cheon J, Yoo C, Hong J, Kim H, Lee DW, Lee M, Kim J, Kim I, Oh SB, Hwang JE, Chon H, Lim H. 955P Prognostic factor analysis of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: Korean cancer study group (KCSG) study. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.175] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
34
|
Park Y, Kim I, Kim H, Kang K. Development of a thermal-hydraulic analysis code for thermal sizing of once-through steam generators for SMR. Progress in Nuclear Energy 2021. [DOI: 10.1016/j.pnucene.2021.103883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
35
|
Lim DH, Casadei-Gardini A, Lee M, Lonardi S, Kim J, Masi G, Chon H, Rimini M, Kim I, Cheon J, Hwang JE, Kang J, Lim H, Yoo C. 952P Prognostic implication of serum alpha-fetoprotein in patients with unresectable hepatocellular carcinoma treated with regorafenib. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
36
|
Hwang T, Yoon M, Kim M, Kim I, Yu H, Kim T, Uhm J, Kim J, Joung B, Lee M, Pak H. Clinical and electrophysiological characteristics of extra-pulmonary vein triggers in patients who underwent catheter ablation for atrial fibrillation. Europace 2021. [DOI: 10.1093/europace/euab116.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Extra-pulmonary vein (PV) triggers play significant roles in atrial fibrillation (AF) recurrence after AF catheter ablation (AFCA).
Purpose
We explore the clinical and electrophysiological characteristics of extra-PV triggers in de novo and repeat-AFCA procedure.
Methods
We included 2,151 patients who had de novo AFCA and 319 repeat AFCA (female 28.0%, 59.1 ± 10.8 years old, paroxysmal AF 65.1%) those underwent post-procedural isoproterenol (ISO) provocation tests. We analysed the clinical, electrophysiological, and procedure-related factors associated with extra-PV triggers.
Results
Extra-PV triggers were documented in 11.9% (1.19 ± 0.42 foci) after de novo-AFCA and 27.0% (1.37 ± 0.65 foci) after repeat-AFCA (p = 0.004). LA volume index (OR 1.02 [1.01-1.03], p = 0.004), history of vascular disease (OR 0.55[0.31-0.91], p = 0.028) and Lead I amplitude of electrocardiogram (OR <0.01 [<0.01-0.62], p = 0.032) were independently associated with the existence of extra-PV triggers in de-novo procedure. Women (OR 1.84 [1.03-3.25], p = 0.037) and LA appendage volume (OR 1.04 [1.01-1.07] p = 0.027) were independently associated with extra-PV triggers during the redo-mapping procedure. Septum (28.4%), coronary sinus (24.0%), and superior vena cava (19.6%) were common extra-PV foci, and septal foci were more commonly found in repeat mapping (38.4% vs. 25.0%, p = 0.025). Among 65 patients who showed extra-PV at the repeat procedures, 19 (29.2%) matched with previous focal or empirical extra-PV ablation sites and 9 (13.8%) were multiple or unmappable sites. AF recurrence rates were significantly higher in both patients with extra-PV triggers after de novo procedures (Log-rank P <0.001; HR 1.93 [1.58-2.36], p= <0.001) and repeat procedures (Log-rank P <0.001, HR 1.87 [1.29-2.70], p= <0.001).
Conclusion
ISO provoked extra-PV triggers commonly found in AF patients with significant remodelling and previous empirical or focal extra-PV ablations. Existence of extra-PV triggers were independently associated with poorer rhythm outcome after both de novo and repeat AFCA. Denovo AF ablation outcome OverallExtra-PV triggers (-)Extra-PV triggers (+)p-value(n = 2151)(n = 1895)(n = 256)Age, yrs58.98 ± 10.9558.73 ± 11.0360.76 ± 10.200.006Male, (%)1550 ( 72.1)1389 ( 73.3)161 ( 62.9)0.001Follow up duration, month50.30 (37.71)51.65 (37.95)40.71 (34.58)<0.001Early recurrence (%)579 ( 27.8)455 ( 24.9)124 ( 48.4)<0.001Clinical recurrence (%)699 ( 33.6)584 ( 32.0)115 ( 44.9)<0.001Abstract Figure. AF free survival according to Extra PVT
Collapse
Affiliation(s)
- T Hwang
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - M Yoon
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - M Kim
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - I Kim
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - H Yu
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - T Kim
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - J Uhm
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - J Kim
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - B Joung
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - M Lee
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| | - H Pak
- Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Republic of)
| |
Collapse
|
37
|
Kim E, Cho MR, Byun SH, A Lim J, Chae S, Choi WK, Kim I, Kim J. Sympathetic predominance before tourniquet deflation is associated with a reduction in arterial blood pressure after tourniquet deflation during total knee arthroplasty. Physiol Res 2021; 70:401-412. [PMID: 33982581 DOI: 10.33549/physiolres.934639] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
High dependency of arterial blood pressure (ABP) on enhanced sympathetic activity, which maintains vascular tone, leads to hypotension after hemodynamic insults that blunt the sympathetic activity. Therefore, we hypothesized that sympathovagal balance before tourniquet deflation (TD) determines the extent of a reduction in ABP after TD during total knee arthroplasty (TKA). Fifty-four hypertensive female patients undergoing TKA under spinal anesthesia were analyzed. The sympathovagal balance [low-to-high frequency ratio of heart rate variability (LF/HF)] before TD was defined as (LF/HF during 5 min before TD-preanesthetic LF/HF)/preanesthetic LF/HF (%). An increase in its value represents a shift in sympathovagal balance toward sympathetic predominance. The percent change in the mean ABP (MAP) after TD was defined as (minimum MAP during 10 min after TD-averaged MAP during 5 min before TD)/averaged MAP during 5 min before TD (%). Simple linear regression was performed to assess the correlation between the sympathovagal balance before TD and change in MAP after TD. The correlation was also assessed by multiple linear regression controlling for age, duration of tourniquet inflation, and spinal anesthesia-induced hypotension. Thirty-two minutes (on average) after tourniquet inflation, the MAP was decreased by 12.1 (-3.0 to 47.9) % [mean (range)] upon TD (P<0.001). The sympathovagal balance before TD was negatively proportional to the change in MAP after TD in both simple and multiple linear regression models (R2=0.323 and 0.340, P<0.001). A shift in sympathovagal balance toward sympathetic predominance before TD is associated with a decrease in ABP after TD.
Collapse
Affiliation(s)
- E Kim
- Department of Anesthesiology and Pain Medicine, Daegu Catholic University Medical Center, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea.
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Rokkas S, Sethi B, Kim I. 317 Why Are We Cancelling Theatre Cases at Ealing Hospital? What Can Be Done? Br J Surg 2021. [DOI: 10.1093/bjs/znab134.401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Introduction
Following a recent spate of on the day cancellation of elective operations being cancelled on the day of surgery, a need for a wider review was felt. Our aim was to identify the causes behind these cancellations.
Method
Retrospective data collection was performed to categorise patients according to the reason for cancellation. Analysis consisted of case presentations being prepared and presented to the surgical consultants.
Results
A total of 130 operations were cancelled on the day of surgery. 22 patients were cancelled due to the procedure not being required and 10 patients were cancelled due to insufficient pre-operative investigations.
Analysis of the 32 cases demonstrated that the majority of cancelled patients were seen and listed for surgery after clinical review by the registrar without involvement of the consultant.
Some cancellations occurred when the consultant responsible for listing the patient was different of the operating consultant.
Both factors lead to differences in opinion arising on the day of surgery.
Conclusions
Ensuring patients are only listed after discussion with the consultant would reduce cancellations arising from lack of experience and clinical misjudgment of the registrar. It would also ensure that cases added to the pooled operating lists are less subjective in their indication and readiness.
Collapse
Affiliation(s)
- S Rokkas
- Ealing Hospital-LNWH, London, United Kingdom
| | - B Sethi
- Ealing Hospital-LNWH, London, United Kingdom
| | - I Kim
- Ealing Hospital-LNWH, London, United Kingdom
| |
Collapse
|
39
|
Park HS, Kang B, Chon HJ, Im HS, Lee CK, Kim I, Kang MJ, Hwang JE, Bae WK, Cheon J, Park JO, Hong JY, Kang JH, Kim JH, Lim SH, Kim JW, Kim JW, Yoo C, Choi HJ. Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG). ESMO Open 2021; 6:100049. [PMID: 33578192 PMCID: PMC7878976 DOI: 10.1016/j.esmoop.2021.100049] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Revised: 12/31/2020] [Accepted: 01/03/2021] [Indexed: 12/16/2022] Open
Abstract
Background There is no clear consensus on the recommended second-line treatment for patients with metastatic pancreatic cancer who have disease progression following gemcitabine-based therapy. We retrospectively evaluated the clinical outcomes of liposomal irinotecan (nal-IRI) plus fluorouracil/leucovorin (FL) and FOLFIRINOX (fluorouracil, leucovorin, irinotecan, and oxaliplatin) in patients who had failed on the first-line gemcitabine-based therapy. Patients and methods From January 2015 to August 2019, 378 patients with MPC who had received nal-IRI/FL (n = 104) or FOLFIRINOX (n = 274) as second-line treatment across 11 institutions were included in this retrospective study. Results There were no significant differences in baseline characteristics between groups, except age and first-line regimens. With a median follow-up of 6 months, the median progression-free survival (PFS) was 3.7 months with nal-IRI/FL versus 4.6 months with FOLFIRINOX (P = 0.44). Median overall survival (OS) was 7.7 months with nal-IRI/FL versus 9.7 months with FOLFRINOX (P = 0.13). There was no significant difference in PFS and OS between the two regimens in the univariate and multivariate analyses. The subgroup analysis revealed that younger age (<70 years) was associated with better OS with FOLFIRINOX. In contrast, older age (≥70 years) was associated with better survival outcomes with nal-IRI/FL. Adverse events were manageable with both regimens; however, the incidence of grade 3 or higher neutropenia and peripheral neuropathy was higher in patients treated with FOLFIRINOX than with nal-IRI/FL. Conclusions Second-line nal-IRI/FL and FOLFIRINOX showed similar effectiveness outcomes after progression following first-line gemcitabine-based therapy. Age could be the determining factor for choosing the appropriate second-line therapy. This multicenter retrospective study investigated nal-IRI/FL and FOLFIRINOX outcomes after gemcitabine-based therapy. We found no significant differences in outcome between nal-IRI/FL and FOLFIRINOX treatment. Both regimens were well tolerated; however, neutropenia and peripheral neuropathy were more frequent with FOLFIRINOX. Age (cut-off, 70 years) showed differential efficacy between chemotherapy regimens.
Collapse
Affiliation(s)
- H S Park
- Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Seoul, Korea
| | - B Kang
- Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
| | - H J Chon
- Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
| | - H-S Im
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - C-K Lee
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
| | - I Kim
- Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - M J Kang
- Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - J E Hwang
- Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Gwangju, Korea
| | - W K Bae
- Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Gwangju, Korea
| | - J Cheon
- Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea
| | - J O Park
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea
| | - J Y Hong
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea
| | - J H Kang
- Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea
| | - J H Kim
- Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea
| | - S H Lim
- Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
| | - J W Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - J-W Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - C Yoo
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
| | - H J Choi
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
| |
Collapse
|
40
|
Shin SH, Kim I, Lee JE, Lee M, Park JW. Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer. Oncogene 2020; 39:5839-5854. [PMID: 32796959 DOI: 10.1038/s41388-020-01418-5] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2020] [Revised: 07/29/2020] [Accepted: 08/04/2020] [Indexed: 12/14/2022]
Abstract
Identification of pro-metastatic genomic alterations is urgently needed to help understand and prevent the fatal course of prostate cancer. Here, we found that the transcription factor EGR3, located at chromosome 8p21.3, is a critical metastasis suppressor. Aberrant deletion of EGR3 was found in up to 59.76% (deep deletions, 16.87%; shallow deletions, 42.89%) of prostate cancer patients. In informatics analysis, EGR3 loss was associated with prostate cancer progression and low survival rates. EGR3 expression inversely correlated with the expressions of epithelial-to-mesenchymal transition (EMT) and metastasis-related gene sets in prostate cancer tissues. In prostate cancer cells, EGR3 blocked the EMT process and suppressed cell migration and invasion. In a mouse model for cancer metastasis, EGR3 overexpression significantly suppressed bone metastases of PC3 and 22Rv1 prostate cancer cells. Mechanistically, EGR3 transcriptionally activated ZFP36, GADD45B, and SOCS3 genes by directly binding to their promoter regions. The EMT-inhibitory and tumor-suppressive roles of the EGR3 downstream genes were identified through in vitro and in silico analyses. Together, our results showed that EGR3 may be a biomarker to predict clinical outcomes and that it plays an important role in the metastatic progression of prostate cancer.
Collapse
Affiliation(s)
- Seung-Hyun Shin
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.,Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea.,Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Iljin Kim
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.,Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea.,Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.,Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Jae Eun Lee
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.,Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea.,Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Mingyu Lee
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.,Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea.,Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.,Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, South Korea.,Obstructive Upper airway Research (OUaR) Laboratory, Seoul National University College of Medicine, Seoul, South Korea
| | - Jong-Wan Park
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea. .,Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea. .,Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. .,Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, South Korea.
| |
Collapse
|
41
|
Seo HS, Jeong EK, Choi S, Kwon Y, Park HJ, Kim I. Changes of Neurotransmitters in Youth with Internet and Smartphone Addiction: A Comparison with Healthy Controls and Changes after Cognitive Behavioral Therapy. AJNR Am J Neuroradiol 2020; 41:1293-1301. [PMID: 32616578 DOI: 10.3174/ajnr.a6632] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2018] [Accepted: 05/01/2020] [Indexed: 01/04/2023]
Abstract
BACKGROUND AND PURPOSE Neurotransmitter changes in youth addicted to the Internet and smartphone were compared with normal controls and in subjects after cognitive behavioral therapy. In addition, the correlations between neurotransmitters and affective factors were investigated. MATERIALS AND METHODS Nineteen young people with Internet and smartphone addiction and 19 sex- and age-matched healthy controls (male/female ratio, 9:10; mean age, 15.47 ± 3.06 years) were included. Twelve teenagers with Internet and smartphone addiction (male/female ratio, 8:4; mean age, 14.99 ± 1.95 years) participated in 9 weeks of cognitive behavioral therapy. Meshcher-Garwood point-resolved spectroscopy was used to measure γ-aminobutyric acid and Glx levels in the anterior cingulate cortex. The γ-aminobutyric acid and Glx levels in the addicted group were compared with those in controls and after cognitive behavioral therapy. The γ-aminobutyric acid and Glx levels correlated with clinical scales of Internet and smartphone addiction, impulsiveness, depression, anxiety, insomnia, and sleep quality. RESULTS Brain parenchymal and gray matter volume-adjusted γ-aminobutyric acid-to-creatine ratios were higher in subjects with Internet and smartphone addiction (P = .028 and .016). After therapy, brain parenchymal- and gray matter volume-adjusted γ-aminobutyric acid-to-creatine ratios were decreased (P = .034 and .026). The Glx level was not statistically significant in subjects with Internet and smartphone addiction compared with controls and posttherapy status. Brain parenchymal- and gray matter volume-adjusted γ-aminobutyric acid-to-creatine ratios correlated with clinical scales of Internet and smartphone addictions, depression, and anxiety. Glx/Cr was negatively correlated with insomnia and sleep quality scales. CONCLUSIONS The high γ-aminobutyric acid levels and disrupted balance of γ-aminobutyric acid-to-Glx including glutamate in the anterior cingulate cortex may contribute to understanding the pathophysiology and treatment of Internet and smartphone addiction and associated comorbidities.
Collapse
Affiliation(s)
- H S Seo
- From the Department of Radiology (H.S.S.), Korea University Ansan Hospital, Ansan, Korea
| | - E-K Jeong
- Utah Center for Advanced Imaging Research (E.-K.J.), University of Utah, Salt Lake City, Utah
| | - S Choi
- Department of Psychology (S.C., Y.K.), Duksung Women's University, Seoul, Korea
| | - Y Kwon
- Department of Psychology (S.C., Y.K.), Duksung Women's University, Seoul, Korea
| | - H-J Park
- Department of Nuclear Medicine (H.-J.P.), Yonsei University College of Medicine, Seoul, Korea
| | - I Kim
- Siemens Healthcare (I.K.), Seoul, Korea
| |
Collapse
|
42
|
Wolf JR, Xie Y, Kim I, Pentland A, Pentland B. 472 Visit complexity reflects billed level of service and documentation burden. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
43
|
Kim I, Park JW. Hypoxia-driven epigenetic regulation in cancer progression: A focus on histone methylation and its modifying enzymes. Cancer Lett 2020; 489:41-49. [PMID: 32522693 DOI: 10.1016/j.canlet.2020.05.025] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 04/28/2020] [Accepted: 05/20/2020] [Indexed: 02/08/2023]
Abstract
The mechanism underlying hypoxia-driven chromatin remodeling is a long-lasting question. For the last two decades, this question has been resolved in part. It is now widely agreed that hypoxia dynamically changes the methylation status of histones to control gene expression. Hypoxia-inducible factor (HIF) plays a central role in cellular responses to hypoxia through transcriptional activation of numerous genes. At least in part, the hypoxic regulation of histone methylation is attributed to the HIF-mediated expression of histone modifying enzymes. Protein hydroxylation and histone demethylation have emerged as the oxygen sensing processes because they are catalyzed by a family of 2-oxoglutarate (2OG)-dependent dioxygenases whose activities depend upon the ambient oxygen level. Recently, it has been extensively investigated that the 2OG dioxygenases oxygen-dependently regulate histone methylation. Nowadays, the hypoxic change in the histone methylation status is regarded as an important event to drive malignant behaviors of cancer cells. In this review, we introduced and summarized the cellular processes that govern hypoxia-driven regulation of histone methylation in the context of cancer biology. We also discussed the emerging roles of histone methyltransferases and demethylases in epigenetic response to hypoxia.
Collapse
Affiliation(s)
- Iljin Kim
- Department of Pharmacology, Cancer Research Institute, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Jong-Wan Park
- Department of Pharmacology, Cancer Research Institute, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
| |
Collapse
|
44
|
Kim JH, Kim I, Kang CK, Jun KI, Yoo SH, Chun JY, Jung J, Kim YJ, Kim DY, Jo HB, Kim DY, Koh Y, Shin DY, Hong J, Kim NJ, Yoon SS, Kim TS, Park WB, Oh MD. Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial. Clin Microbiol Infect 2020; 27:69-75. [PMID: 32272171 DOI: 10.1016/j.cmi.2020.03.038] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2020] [Revised: 03/30/2020] [Accepted: 03/31/2020] [Indexed: 12/14/2022]
Abstract
OBJECTIVES Recently, rapid phenotypic antimicrobial susceptibility testing (AST) based on microscopic imaging analysis has been developed. The aim of this study was to determine whether implementation of antimicrobial stewardship programmes (ASP) based on rapid phenotypic AST can increase the proportion of patients with haematological malignancies who receive optimal targeted antibiotics during early periods of bacteraemia. METHODS This randomized controlled trial enrolled patients with haematological malignancies and at least one positive blood culture. Patients were randomly assigned 1:1 to conventional (n = 60) or rapid phenotypic (n = 56) AST. The primary outcome was the proportion of patients receiving optimal targeted antibiotics 72 hr after blood collection for culture. RESULTS The percentage receiving optimal targeted antibiotics at 72 hr was significantly higher in the rapid phenotypic AST group (45/56, 80.4%) than in conventional AST group (34/60, 56.7%) (relative risk (RR) 1.42, 95% confidence interval (CI) 1.09-1.83). The percentage receiving unnecessary broad-spectrum antibiotics at 72 hr was significantly lower (7/26, 12.5% vs 18/60, 30.0%; RR 0.42, 95% CI 0.19-0.92) and the mean time to optimal targeted antibiotic treatment was significantly shorter (38.1, standard deviation (SD) 38.2 vs 72.8, SD 93.0 hr; p < 0.001) in the rapid phenotypic AST group. The mean time from blood collection to the AST result was significantly shorter in the rapid phenotypic AST group (48.3, SD 17.6 vs 83.1, SD 22.2 hr). DISCUSSION ASP based on rapid phenotypic AST can rapidly optimize antibiotic treatment for bacteraemia in patients with haematological malignancy. Rapid phenotypic AST can improve antimicrobial stewardship in immunocompromised patients.
Collapse
Affiliation(s)
- J-H Kim
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - I Kim
- Division of Haematology-Oncology, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - C K Kang
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - K-I Jun
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - S H Yoo
- Division of Haematology-Oncology, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - J Y Chun
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - J Jung
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - Y J Kim
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - D Y Kim
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - H B Jo
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - D Y Kim
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - Y Koh
- Division of Haematology-Oncology, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - D-Y Shin
- Division of Haematology-Oncology, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - J Hong
- Division of Haematology-Oncology, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - N J Kim
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - S-S Yoon
- Division of Haematology-Oncology, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| | - T S Kim
- Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
| | - W B Park
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea.
| | - M-D Oh
- Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
45
|
Kim I, Rossano J, Kim H, Kim J, Kwon A, Cherikh W, Vece G, Stehlik J, Youn J. Predictors and Clinical Outcomes of Lymphoproliferative Disorders in Heart Transplant Recipients. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
46
|
Kim I, Wu G, Chai N, Jordan S, Klein A. Five Treatment Strategies to Suppress Donor Specific Antibodies: Highlights from a Decade of Research Experience in a Mouse Model of Allo-Sensitization. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
47
|
Tetsuno K, Ajimura S, Akutagawa K, Batpurev T, Chan WM, Fushimi K, Hazama R, Iida T, Ikeyama Y, Khai BT, Kishimoto T, Lee KK, Li X, Matsuoka K, Matsuoka K, Mizukoshi K, Mori Y, Nakajima K, Noithong P, Nomachi M, Ogawa I, Ohsumi H, Ozawa K, Shimizu K, Shokati M, Soberi F, Suzuki K, Takemoto Y, Takihira Y, Tamagawa Y, Tozawa M, Trang VTT, Umehara S, Yamamoto K, Yoshida S, Kim I, Kwon DH, Kim HL, Lee HJ, Lee MK, Kim YH. Status of 48Ca double beta decay search and its future prospect in CANDLES. ACTA ACUST UNITED AC 2020. [DOI: 10.1088/1742-6596/1468/1/012132] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
48
|
Khang YH, Lim D, Bahk J, Kim I, Kang HY, Chang Y, Jung-Choi K. Comparison of the difference between income quintiles with the slope index of inequality. Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz186.603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The difference between income quintiles in health is relatively well accepted by the general public as a measure of health inequality. However, the slope index of inequality (SII) in health reflects the patterns of all social groups, including the middle 60%, and it could therefore be considered more academically desirable. If these two measures are closely correlated, the widespread use of the difference between income quintiles in health would be better supported. This study was conducted to compare differences between income quintiles in life expectancy (LE) and healthy life expectancy (HLE) with the SII.
Methods
Data on LE and HLE by income quintile from all 252 subnational districts of Korea were obtained using the National Health Information Database of the National Health Insurance Service and the Korea Community Health Survey. The SII was estimated with linear regression analysis, and Pearson correlation coefficients between differences between income quintiles and the SII were computed.
Results
The correlation coefficients between differences between income quintiles and the SII were generally high: 0.97 (95% CI: 0.96-0.98) for LE in men and women combined and 0.96 (95% CI: 0.94-0.97) for HLE in men and women combined. In most districts, the SII was greater than the difference between income quintiles.
Conclusions
Differences between income quintiles were closely correlated with the SII. The widespread use of differences between income quintiles in health as a measure of health inequality may be preferable for communicating results of health inequality measurements to the public.
Key messages
Differences in life expectancy and health life expectancy between income quintiles were closely correlated with the slope index of inequality in life expectancy and healthy life expectancy. The widespread use of differences between income quintiles in health as a measure of health inequality may be preferable for communicating results of health inequality measurements to the public.
Collapse
Affiliation(s)
- Y H Khang
- Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, South Korea
- Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul, South Korea
| | - D Lim
- Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul, South Korea
| | - J Bahk
- Department of Public Health, Keimyung University, Daegu, South Korea
| | - I Kim
- Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, South Korea
| | - H Y Kang
- Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, South Korea
| | - Y Chang
- Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, South Korea
| | - K Jung-Choi
- Department of Occupational and Environmental Medicine, Ewha Womans University School of Medicine, Seoul, South Korea
| |
Collapse
|
49
|
Azimov A, Kim I. The better outcome by using antiviral drugs in stroke patients with diabetes mellitus and herpes infection. J Neurol Sci 2019. [DOI: 10.1016/j.jns.2019.10.525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
50
|
Park H, Shin DY, Kim I, Sohn SK, Koh Y, Lee JH, Lee KH, Kim DY, Kim HJ, Ahn JS, Lee JO, Bang SM, Cheong JW, Park SG, Park S, Lee Y, Ahn SY. Use of droplet digital polymerase chain reaction for detecting minimal residual disease: A prospective, multi-institutional study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz251.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|